Researchers at Adaptimmune and the University of  Pennsylvania announce the approval of an IND and opening for enrolment of the first ever study using engineered T cells to treat HIV

October 7th, 2009 Oxford, UK and Philadelphia, PA: 7 October 2009. Researchers at Adaptimmune Limited and the University of Pennsylvania School of Medicine announce the approval of an Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) and opening for enrolment of the first ever study using patients’ cells carrying an [...]